N. Milanović

Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas

Z. Magić, B. Cikota-Aleksic, O. Tarabar, 2014, International Journal of Clinical Oncology.

Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies

O. Cordero, A. Damjanović, B. Kolundžija, 2013, Leukemia & lymphoma.

Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study

S. Jelić, N. Babović, N. Milanović, 2002, Melanoma research.

A two-step reevaluation of high-dose amsacrine for advanced carcinoma of the upper aerodigestive tract: a pilot phase II study.

S. Jelić, Z. Tomašević, N. Milanović, 1997, Journal of chemotherapy.

Cardioprotection with ICRF-187 (Cardioxane) in patients with advanced breast cancer having cardiac risk factors for doxorubicin cardiotoxicity, treated with the FDC regimen

S. Radulović, S. Jelić, S. Bošnjak, 1995, Supportive Care in Cancer.

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.

S. Jelić, N. Babović, N. Milanović, 1997, European journal of cancer.

Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma.

S. Jelić, N. Milanović, M. Petrovic, 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia.

S. Jelić, N. Milanović, M. Marinkovic, 1997, Neoplasma.

Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT)

S. Jelić, N. Milanović, I. Pendjer, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

High-Dose Epirubicin-Cisplatin Chemotherapy for Advanced Soft Tissue Sarcoma

S. Jelić, N. Milanović, Z. Tomašević, 1990, Tumori.